The 18 analysts offering 12-month price forecasts for Abbott Laboratories have a median target of 125.50, with a high estimate of 150.00 and a low estimate of 95.00. The median estimate represents a +24.53% increase from the last price of 100.78.
The current consensus among 23 polled investment analysts is to Buy stock in Abbott Laboratories. This rating has held steady since August, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $0.93
Reporting Date Oct 19
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.